Defining the predictors of the placebo response in irritable bowel syndrome
Authors:
- Charles N. BernsteinCBCharles N. Bernstein
- 1 March 2005
- journal article
- review article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 3 (3) , 237-247
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regressionPsychopharmacology, 2003
- Placebo Response in Studies of Major DepressionJAMA, 2002
- A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel SyndromeArchives of internal medicine (1960), 2001
- Treatment of Irritable Bowel Syndrome With Chinese Herbal MedicineJAMA, 1998
- Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: A prospective, randomized trialJournal of Gastroenterology, 1997
- Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndromeDigestive Diseases and Sciences, 1995
- Effect of leuprolide acetate in patients with moderate to severe functional bowel diseaseDigestive Diseases and Sciences, 1994
- Controlled treatment trials in the irritable bowel syndrome: A critiqueGastroenterology, 1988
- Effects of desipramine on irritable bowel syndrome compared with atropine and placeboDigestive Diseases and Sciences, 1987
- Prifinium bromide in the treatment of the irritable colon syndromeGastroenterology, 1979